6533b85ffe1ef96bd12c278b
RESEARCH PRODUCT
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome
F. D’antoniPiero Luigi AlmasioR. Di StefanoAnna LicataA. IacòAntonio CraxìGiuseppe TarantinoF. BarbariaSalvatore PettaV. Di MarcoA. Ciacciosubject
Hepatologybusiness.industryImmunologyGastroenterologyMedicineAcute hepatitis CbusinessB-cell activating factoryear | journal | country | edition | language |
---|---|---|---|---|
2008-05-01 |